InsidersTradesSigma
PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT Stock: price and management transactions · Italy · Consob
CONSOB:pharmanutra-pr-pharmanutra-phn-the-board-of-director-approves-the-2022-sustainab-940c9dIT·ConsobHealth Care
Follow the PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT share price and the full management transaction log of the company, a listed equity based in Italy. Shares are listed on IT IT, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY REPORT has logged 0 reports. The full history is free.
0
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Declarations0 total
No declarations found
0 of 0 declarations